anti eea1 primary antibodies (Fisher Scientific)
Structured Review

Anti Eea1 Primary Antibodies, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+eea1+primary+antibodies/2+anti+epr2533+primary/bio_rxiv__64898__2026__01__19__700329-92-30-33
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Kv1.3 palmitoylation regulates spatial distribution and channel removal from the immunological synapse"
Article Title: Kv1.3 palmitoylation regulates spatial distribution and channel removal from the immunological synapse
Journal: bioRxiv
doi: 10.64898/2026.01.19.700329
Figure Legend Snippet: Palmitoylation facilitates Kv1.3 endocytosis. (A) Representative confocal images of HEK293 cells transfected with either WT or Cys less Kv1.3 YFP. The cells were incubated in the absence (-PMA) or presence (+PMA) of PMA for 30 min, after which early endosomes (EEA1) were identified. The plasma membrane (PM) and nuclei were stained with wheat germ agglutinin (WGA) and DAPI, respectively. The merged panels show the indicated colocalizations in white. Green, Kv1.3 channels; magenta, cell markers (EEA1 or PM). Scale bars represent 10 μm. (B) Manders overlapping coefficients between Kv1.3 and EEA1 (top panel) and between Kv1.3 and the PM (bottom panel). Data are presented as the means ± SEs of n > 30 cells from 3 independent experiments. ***p < 0.001 by one-way ANOVA with post hoc Tukey test. (C) Membrane protein biotinylation assay of HEK293 cells transfected with either WT or Cys less Kv1.3 YFP and incubated in the absence (-PMA) or presence (+PMA) of PMA for 30 min to trigger endocytosis. Calnexin was used as a negative control because it is a transmembrane protein located in the ER and is absent at the PM, and β-actin was used as a loading control. (D) Quantification of Kv1.3 biotinylation in arbitrary units (A.U.). The data are presented as the means ± SEs of 4 independent experiments. *p < 0.05 by one-way ANOVA with post hoc Tukey test.
Techniques Used: Transfection, Incubation, Clinical Proteomics, Membrane, Staining, Cell Surface Biotinylation Assay, Negative Control, Control
Related Articles
Incubation:Article Title: Kv1.3 palmitoylation regulates spatial distribution and channel removal from the immunological synapse Article Snippet: For plasma membrane labeling, the Blocking Assay:Article Title: Kv1.3 palmitoylation regulates spatial distribution and channel removal from the immunological synapse Article Snippet: For plasma membrane labeling, the Transfection:Article Title: Kv1.3 palmitoylation regulates spatial distribution and channel removal from the immunological synapse Article Snippet: For plasma membrane labeling, the Clinical Proteomics:Article Title: Kv1.3 palmitoylation regulates spatial distribution and channel removal from the immunological synapse Article Snippet: For plasma membrane labeling, the Membrane:Article Title: Kv1.3 palmitoylation regulates spatial distribution and channel removal from the immunological synapse Article Snippet: For plasma membrane labeling, the Staining:Article Title: Kv1.3 palmitoylation regulates spatial distribution and channel removal from the immunological synapse Article Snippet: For plasma membrane labeling, the Cell Surface Biotinylation Assay:Article Title: Kv1.3 palmitoylation regulates spatial distribution and channel removal from the immunological synapse Article Snippet: For plasma membrane labeling, the Negative Control:Article Title: Kv1.3 palmitoylation regulates spatial distribution and channel removal from the immunological synapse Article Snippet: For plasma membrane labeling, the Control:Article Title: Kv1.3 palmitoylation regulates spatial distribution and channel removal from the immunological synapse Article Snippet: For plasma membrane labeling, the |

